A Study to Refine and Modify the Granulocyte Antibody Test to Provide Patients the Most Sensitive and Accurate Blood Serum Assay Available.


About this study

The purpose of this study is to refine and modify the Granulocyte Antibody test to include an immunofluorescent assay and a granulocyte agglutination test.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria

  • Able to provide informed consent
  • At least 18 years of age
  • Of East Asian and African American descent for group two

Exclusion Criteria 

  • < 18 years of age
  • Not capable of consenting on their own

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Manish Gandhi, M.D.

Open for enrollment

Contact information:

Thomas Auth B.S.



More information


Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available